Related Experiment Videos

Musculoskeletal comorbidities in cardiac patients: prevalence, predictors, and health services utilization

Susan Marzolini1, Paul I Oh, David Alter

  • 1Toronto Rehabilitation Institute, Toronto, ON, Canada. Marzolini.susan@torontorehab.on.ca

Archives of Physical Medicine and Rehabilitation
|March 20, 2012
PubMed

Insights

Over half of patients with coronary artery disease (CAD) also have musculoskeletal conditions (MSKCs). These patients face higher cardiovascular risk and increased healthcare use, yet receive fewer cardiac rehabilitation referrals.

Area of Science:

  • Cardiology
  • Rheumatology
  • Public Health

Background:

  • Musculoskeletal conditions (MSKCs) are common comorbidities.
  • Understanding their impact on coronary artery disease (CAD) patients is crucial for comprehensive care.

Purpose of the Study:

  • To determine the prevalence of MSKCs in CAD patients.
  • To identify predictors of MSKCs in this population.
  • To analyze healthcare utilization patterns based on MSKC status.

Main Methods:

  • Cross-sectional, observational study involving 1803 CAD patients across 11 Ontario hospitals.
  • Data collected via questionnaires and chart extraction during hospitalization and 1 year later.
  • Health care utilization assessed through mailed questionnaires.

Main Results:

  • 56% of CAD patients had MSKCs, predominantly arthritis/joint pain.
  • Predictors included older age, female sex, white ethnicity, higher BMI, depressive symptoms, and lower income.
  • Patients with MSKCs showed increased emergency visits, hospital admissions, and primary care visits, but fewer cardiac rehabilitation referrals.

Conclusions:

  • MSKCs are highly prevalent in CAD patients, contributing to increased cardiovascular risk.
  • These comorbidities significantly impact healthcare utilization.
  • Despite higher needs, MSKC patients with CAD receive less cardiac rehabilitation, highlighting a gap in care.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...